United States · FDA National Drug Code directory
Felbamate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65162-734_28bca98d-c89a-492a-a3e5-405098e33919
- Product NDC
- 65162-734
- Form
- TABLET
- Composition / generic term
- Felbamate
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110916
- Source listing expiry
- 20261231
Source-listed ingredients
- FELBAMATE — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (65162-734-03) · 65162-734-03
- 90 TABLET in 1 BOTTLE (65162-734-09) · 65162-734-09
- 270 TABLET in 1 BOTTLE (65162-734-27) · 65162-734-27
- 500 TABLET in 1 BOTTLE (65162-734-50) · 65162-734-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →